# IOL Chemicals & Pharmaceuticals Ltd (IOLCP)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹121.17
Day Change: +1.36%
52W High: ₹126.66
52W Low: ₹67.19
Market Cap: ₹3,183 Cr

## Valuation
P/E: 27.45
P/B: 1.82
EPS: ₹3.95
Book Value: ₹59.6
Dividend Yield: 0.94%

## Returns
1Y Return: 10.35%

## Profitability
ROE: 0%
ROCE: 8.71%
Debt/Equity: 0.09
Revenue Growth: 10.9%
Profit Growth: 0%
EBITDA Margin: 10.68%
Operating Margin: 6.39%

## About
IOL Chemicals & Pharmaceuticals Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: IOL Chemicals & Pharmaceuticals Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Notice Of The Board Meeting
- Announcement: Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
- BSE Filing: Board Meeting Intimation for Notice Of The Board Meeting

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:58:45.951Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:45.951Z
Quant Updated: 2026-05-18T22:58:45.951Z
Sentiment Updated: 2026-05-18T22:58:45.951Z
Financials Status: current
Financials Updated: 2026-05-18T15:30:59.693Z
Financials Last Attempt: 2026-05-18T15:30:59.693Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2023)
Revenue: ₹2184 Cr
Operating Profit: ₹259 Cr (OPM 12%)
Net Profit: ₹168 Cr
Tax: ₹225 Cr

## Annual P&L History
Mar 2023: Rev ₹2184Cr | PAT ₹168Cr | OPM 12%
Mar 2024: Rev ₹2217Cr | PAT ₹139Cr | OPM 10%
Mar 2025: Rev ₹2133Cr | PAT ₹134Cr | OPM 11%

## Balance Sheet (Mar 2023)
Total Assets: ₹1962 Cr
Total Liabilities: ₹1962 Cr
Borrowings: ₹44 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Varinder  Gupta, MD & Whole Time Director
- Vikas  Gupta, Joint Managing Director & Executive Director
- Pardeep Kumar Khanna, Chief Financial Officer
- Damandeep  Singh, President of New Product Development
- Kushal Kumar Rana, Director of Works & Wholetime Director

---
Source: rupiya.io/stocks/iolcp
Disclaimer: For research and education only. Not investment advice.